{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:48:06Z","timestamp":1779310086017,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":339,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) with tumour thrombus (TT) in the inferior vena cava (IVC) or right atrium (RA) is a rare advanced disease state with a poor prognosis. The aim of this study was to examine survival after surgical resection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with HCC and TT of either the IVC or RA, who underwent liver resection between February 1997 and July 2017, were included. Their short- and long-term outcomes and surgical details were analysed retrospectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirty-seven patients were included; 16 patients had TT in the IVC below the diaphragm, eight had TT in the IVC above the diaphragm, and 13 had TT entering the RA. Twelve patients had advanced portal vein TT (portal vein invasion (Vp) greater than Vp3 and Vp4), ten had bilobar disease, and 12 had extrahepatic disease. There were no in-hospital deaths, although two patients died within 90 days. Median survival did not differ between patients who had resection with curative intent (18\u00b77 months) and those with residual tumour in the lung only (20\u00b77 months), but survival was poor for patients with residual tumour in the liver (8\u00b73 months).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Liver resection with thrombectomy for advanced HCC with TT in the IVC or RA is safe and feasible, leading to moderate survival.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/bjs5.50258","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T17:19:05Z","timestamp":1580750345000},"page":"241-251","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Liver resection with thrombectomy for patients with hepatocellular carcinoma and tumour thrombus in the inferior vena cava or right atrium"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-0222","authenticated-orcid":false,"given":"S","family":"Matsukuma","sequence":"first","affiliation":[{"name":"Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine , Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-1129","authenticated-orcid":false,"given":"H","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Osaka International Cancer Institute , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Shindo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine , Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Tokumitsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine , Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine , Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Osaka International Cancer Institute , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine , Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine , Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"2022100812273746900_bjs550258-bib-0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"RESORCE Investigators. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"2022100812273746900_bjs550258-bib-0002","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"2022100812273746900_bjs550258-bib-0003","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"2022100812273746900_bjs550258-bib-0004","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ags3.12251","article-title":"Preoperative lymphocyte-to-monocyte ratio is useful for stratifying the prognosis of hepatocellular carcinoma patients with a low Cancer of the Liver Italian Program score undergoing curative resection","volume":"23","author":"Shimizu","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"2022100812273746900_bjs550258-bib-0005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1072-7515(02)01497-7","article-title":"Removal of hepatocellular carcinoma extending in the right atrium without extracorporal bypass","volume":"195","author":"Georgen","year":"2002","journal-title":"J Am Coll Surg"},{"key":"2022100812273746900_bjs550258-bib-0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jvir.2008.09.030","article-title":"Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors","volume":"20","author":"Lee","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"2022100812273746900_bjs550258-bib-0007","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.gassur.2005.12.011","article-title":"Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case\u2013control series","volume":"10","author":"Le Treut","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"2022100812273746900_bjs550258-bib-0008","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-012-2646-2","article-title":"Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava\/right atrium tumor thrombus: results of a retrospective cohort study","volume":"20","author":"Wang","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2022100812273746900_bjs550258-bib-0009","first-page":"836","article-title":"Budd\u2013Chiari syndrome secondary to intracardiac extension of hepatocellular carcinoma. Two cases treated by radical resection","volume":"48","author":"Sa\u00efsse","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"2022100812273746900_bjs550258-bib-0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00595-017-1619-2","article-title":"Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium","volume":"48","author":"Sakamoto","year":"2018","journal-title":"Surg Today"},{"key":"2022100812273746900_bjs550258-bib-0011","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2008.04.042","article-title":"Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature","volume":"102","author":"Sung","year":"2008","journal-title":"Am J Cardiol"},{"key":"2022100812273746900_bjs550258-bib-0012","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.29225","article-title":"Liver Cancer Study Group of Japan. Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey","volume":"66","author":"Kokudo","year":"2017","journal-title":"Hepatology"},{"key":"2022100812273746900_bjs550258-bib-0013","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2014.04.032","article-title":"Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis","volume":"61","author":"Kokudo","year":"2014","journal-title":"J Hepatol"},{"key":"2022100812273746900_bjs550258-bib-0014","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1499-3872(13)60043-0","article-title":"Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus: a new classification for surgical guidance","volume":"12","author":"Li","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2022100812273746900_bjs550258-bib-0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1477-7819-11-259","article-title":"Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium","volume":"11","author":"Wakayama","year":"2013","journal-title":"World J Surg Oncol"},{"key":"2022100812273746900_bjs550258-bib-0016","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ags3.12233","article-title":"Current topics in liver surgery","volume":"3","author":"Yamazaki","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"2022100812273746900_bjs550258-bib-0017","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ags3.12068","article-title":"Liver resection combined with inferior vena cava resection and reconstruction using artificial vascular graft: a literature review","volume":"2","author":"Tomimaru","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"2022100812273746900_bjs550258-bib-0018","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000493434","article-title":"Surgical outcomes of liver resection combined with inferior vena cava resection and reconstruction with artificial vascular graft","volume":"36","author":"Tomimaru","year":"2019","journal-title":"Dig Surg"},{"key":"2022100812273746900_bjs550258-bib-0019","volume-title":"The General Rules for the Clinical and Pathological Study of Primary Liver Cancer","author":"Liver Cancer Study Group of Japan","year":"2015","edition":"6th"},{"key":"2022100812273746900_bjs550258-bib-0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2022100812273746900_bjs550258-bib-0021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2022100812273746900_bjs550258-bib-0022","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ags3.12065","article-title":"Current topics in the surgical treatments for hepatocellular carcinoma","volume":"2","author":"Ban","year":"2018","journal-title":"Ann Gastroenterol Surg"},{"key":"2022100812273746900_bjs550258-bib-0023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005466","article-title":"Models predicting the risks of six life-threatening morbidities and bile leakage in 14 970 hepatectomy patients registered in the National Clinical Database of Japan","volume":"95","author":"Yokoo","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2022100812273746900_bjs550258-bib-0024","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/hepr.12923","article-title":"Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus","volume":"47","author":"Sakamoto","year":"2017","journal-title":"Hepatol Res"},{"key":"2022100812273746900_bjs550258-bib-0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jjco\/hyx157","article-title":"Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma","volume":"48","author":"Yamanaka","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"2022100812273746900_bjs550258-bib-0026","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00423-014-1230-6","article-title":"Surgical treatment of extrahepatic recurrence of hepatocellular carcinoma","volume":"399","author":"Hirokawa","year":"2014","journal-title":"Langenbecks Arch Surg"},{"key":"2022100812273746900_bjs550258-bib-0027","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1245\/s10434-010-1076-2","article-title":"Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma","volume":"17","author":"Taketomi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"2022100812273746900_bjs550258-bib-0028","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"2022100812273746900_bjs550258-bib-0029","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.surg.2017.05.011","article-title":"Proposal of selection criteria for operative resection of hepatocellular carcinoma with inferior vena cava tumor thrombus incorporating hepatic arterial infusion chemotherapy","volume":"162","author":"Kasai","year":"2017","journal-title":"Surgery"},{"key":"2022100812273746900_bjs550258-bib-0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jhbp.574","article-title":"Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"25","author":"Hatano","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2022100812273746900_bjs550258-bib-0031","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"SARAH Trial Group. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"2022100812273746900_bjs550258-bib-0032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5582\/bst.2018.01261","article-title":"Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: an overview of current evidence according to the different target population","volume":"13","author":"Han","year":"2019","journal-title":"Biosci Trends"},{"key":"2022100812273746900_bjs550258-bib-0033","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/hepr.13067","article-title":"Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-\u03b1 combination therapy for hepatocellular carcinoma with extrahepatic metastases","volume":"48","author":"Nagano","year":"2018","journal-title":"Hepatol Res"},{"key":"2022100812273746900_bjs550258-bib-0034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"2022100812273746900_bjs550258-bib-0035","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"2022100812273746900_bjs550258-bib-0036","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30165-2","article-title":"Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of \u03b1-fetoprotein","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol"},{"key":"2022100812273746900_bjs550258-bib-0037","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1470-2045(15)00050-9","article-title":"Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial","volume":"16","author":"Zhu","year":"2015","journal-title":"Lancet Oncol"},{"key":"2022100812273746900_bjs550258-bib-0038","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N Engl J Med"}],"container-title":["BJS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs5.50258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bjs5.50258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bjs5.50258","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/4\/2\/241\/46351136\/bjs550258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/4\/2\/241\/46351136\/bjs550258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T12:38:25Z","timestamp":1665232705000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjsopen\/article\/4\/2\/241\/6061335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3,24]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs5.50258","relation":{},"ISSN":["2474-9842"],"issn-type":[{"value":"2474-9842","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"2019-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}